Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01768936
Other study ID # TUM-PCT-1
Secondary ID PCTRatio Reevalu
Status Completed
Phase N/A
First received January 10, 2013
Last updated January 15, 2013
Start date January 2009
Est. completion date December 2012

Study information

Verified date January 2013
Source CHIR-Net
Contact n/a
Is FDA regulated No
Health authority Ethics Commission: TUM
Study type Observational

Clinical Trial Summary

Procalcitonin (PCT) serum levels are monitored in patients with secondary peritonitis after initial operative focus elimination to investigate the PCT ratio's impact on decision-making for or against early relaparotomy in the on-demand relaparotomy concept of secondary septic peritonitis.


Recruitment information / eligibility

Status Completed
Enrollment 234
Est. completion date December 2012
Est. primary completion date December 2011
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- age >18 years

- necessity for operative intervention to eliminate an infectious peritoneal / abdominal focus after organ perforation

- abdominal sepsis according to the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference definition

Exclusion Criteria:

- pregnancy

- immunosuppressive medication

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


Locations

Country Name City State
Germany Klinikum rechts der Isar der TU München Munich

Sponsors (1)

Lead Sponsor Collaborator
CHIR-Net

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary prediction of focus elimination: cured patients versus patients with persisting peritonitis (definitions see below) definition of 'focus elimination': patients with intestinal perforation or anastomotic leakage develop (local) peritonitis and consecutive abdominal sepsis. These patients need surgical intervention for focus elimination. This operative intervention aims to eradicate all infectious material and is intended to remove the leaking intestinal lesion. Whether this focus is eliminated or not can be controlled by either planned relaparotomy (normally within 48h after the first operation) or on demand relaparotomy in case of clinical deterioration. The focus can be assumed to be eliminated in all cases where either relaparotomy reveals no ongoing infection or persisting focus and whenever a patient recovers rapidly after initial surgery. participants will be followed for the duration of hospital stay, an expected average of 21 days No